pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
0
catalysts
Phase 2
elraglusib
Neuroblastoma
Glycogen synthase kinase-3 beta
$ACTU
ACTUATE THERAPEUTICS, INC.
0
catalysts
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
0
catalysts
← prev
page 36 of 50
next →
131
Pain
89
Neurology
1
Phase 2
elunetirom
Bipolar I Disorder
Autobahn Therapeutics Inc
0
catalysts
Phase 2
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 2
emicizumab
Hemlibra (emicizumab-kxwh)
Acquired Hemophilia A
Coagulation factor IX and X
Chugai Pharmaceutical Co Ltd
0
catalysts
Phase 2
emodepside
Onchocerciasis (River Blindness)
Bayer AG
0
catalysts
Phase 2
emraclidine
Psychosis
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
emrusolmin
emrusolmin [INN]
Multiple System Atrophy (Multi-System Degeneration)
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
0
catalysts
Phase 2
emugrobart
emugrobart [INN]
Obesity
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
0
catalysts
Phase 2
encoberminogene rezmadenovec
Refractory Angina
XyloCor Therapeutics Inc
0
catalysts
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ATOS
ATOSSA THERAPEUTICS, INC.
0
catalysts
Phase 2
enekinragene inzadenovec
Osteoarthritis
$PCRX
Pacira BioSciences, Inc.
0
catalysts
Phase 2
engasertib
engasertib [INN]
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu Disease)
Vaderis Therapeutics AG
0
catalysts
Phase 2
eniluracil
Metastatic Breast Cancer
Dihydropyrimidine dehydrogenase [NADP(+)]
$PCSA
Processa Pharmaceuticals, Inc.
0
catalysts
Phase 2
enobosarm
Obesity
Androgen receptor
$VERU
VERU INC.
0
catalysts
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORIC
Oric Pharmaceuticals, Inc.
0
catalysts
Phase 2
enzomenib tartrate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
epaldeudomide
epaldeudomide [INN]
Systemic Lupus Erythematosus
Kangpu Biopharmaceuticals Ltd
0
catalysts
Phase 2
epeleuton
epeleuton [INN]
Sickle Cell Disease
Afimmune Biopharma Ltd
0
catalysts
Phase 2
epetraborole
epetraborole [INN]
Mycobacterium avium Infections
$ANTX
AN2 Therapeutics, Inc.
0
catalysts
Phase 2
epsametostat
epsametostat [INN]
Peripheral T-Cell Lymphomas (PTCL)
Shanghai Haihe Biopharma Co Ltd
0
catalysts
Phase 2
esonadogene imvoparvovec
esonadogene imvoparvovec [INN]
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
Wuhan Neurophth Biological Technology Ltd
0
catalysts
Phase 2
estriol
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy)
Estrogen receptor
VaRi Bioscience GmbH
0
catalysts
Phase 2
etigilimab
Adenocarcinoma Of The Gastroesophageal Junction
T-cell immunoreceptor with Ig and ITIM domains
$MREO
Mereo BioPharma Group plc
0
catalysts
Phase 2
etivelcabtagene erigedleucel
Follicular Lymphoma
Cellectis SA
0
catalysts
Phase 2
evalstotug
evalstotug [INN]
Melanoma
$BCAB
BioAtla, Inc.
0
catalysts
Phase 2
evarucabgene autoleucel
Refractory Multiple Myeloma
Nexcella Inc
0
catalysts
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOX
Eloxx Pharmaceuticals, Inc.
0
catalysts